News summary

Concino Biological Research and DevelopmentbestblockchainfornftgamesLyophilized Hib vaccine approved by the State Food and Drug Administration of ChinabestblockchainfornftgamesClinical trials will be launched soon.

Newsletter text

[Clinical trial of Concino Biotech's lyophilized Hib vaccine approved] On April 22, Concino Biotech (06185bestblockchainfornftgames.HK) has been approved by the State Food and Drug Administration of China, and its lyophilized Haemophilus influenzae type b (Hib) conjugate vaccine can be carried out in clinical trials. Haemophilus influenzae is the main pathogen of acute lower respiratory infections in children, with approximately 95% of invasive cases caused by type b. The Hib vaccine developed by Concino Biotech is covalently bonded to purified Hib capsular polysaccharide and tetanus toxoid protein. It is in a lyophilized dosage form. It is expected to induce humoral immunity against Hib and provide protection to recipients.